cerrar
Tagged with China

Roche’s Hong Chow: Back to the Motherland
China’s unbridled growth has spurred a vast number of overseas Chinese to return home to seek new opportunities in their transformed homeland.…

John Yu – CEO, CGeneTech, China
Dr John Yu, co-founder and CEO of CGeneTech, shares the exciting story behind the company’s establishment in 2010; its balanced philosophy on new…

Fendy Yanhui Feng – President, Eisai China
Fendy Yanhui Feng, vice president of Eisai Co., Ltd. and president of Eisai China Holdings Ltd. and Eisai China Inc., shares the significant…

Cecily Gu – Business Executive Officer Greater China,…
Research has established that proper nutrition during hospitalization helps to reduce the number of infections, the duration of treatment needed for…

Samantha Du – Chairman & CEO, Zai Lab, China
Samantha Du, Chairman and CEO of Zai Lab, the flagship China biotech company, shares her inspirational story of being one of the pioneers to forge a…

The Ideal Pharma Country Manager: China (Egon Zehnder)
Lydia Guo, Grace Zhao and Mendy Zhang of executive search firm Egon Zehnder outline some of the latest trends affecting the Chinese pharma sector and…

Jay Dong – General Manager (China and APAC) & Vice…
Jay Dong, founding GM (China and APAC) and Global VP of Cell Signaling Technology, shares the company’s success in the past ten years; the economic…

Orphan Drug Accessibility & Social Medical Coverage in China
Kevin Rufang Huang is the president and founder of the Chinese Organization for Rare Disorders (CORD). A rare disease patient himself, he is…

The Ideal Pharma Country Manager: China (Cornerstone…
What do executive recruitment firms look for when hiring country managers for multinational pharma companies in some of the world’s most challenging…

Lingshi Tan – Founder, Chairman and CEO, dMed, China
Dr Lingshi Tan, chairman and CEO of dMed, shares his strategic insights into the new era of Chinese biotech innovation and how it motivated him to…

John Gong – CEO, 3D Medicines, China
Dr John Gong, CEO of 3D Medicines, shares the company’s ‘3D – diagnostics, data, and drug development’ approach to cancer precision medicine;…

China to Establish National Medical Ethics Committee Post-CRISPR…
China is planning to establish a new national medical ethics committee in the wake of the “CRISPR babies” scandal. The committee will…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here